company background image
540701 logo

Dishman Carbogen Amcis BSE:540701 Stock Report

Last Price

₹220.35

Market Cap

₹34.6b

7D

8.3%

1Y

-10.3%

Updated

22 Feb, 2025

Data

Company Financials

Dishman Carbogen Amcis Limited

BSE:540701 Stock Report

Market Cap: ₹34.6b

540701 Stock Overview

Provides contract research and manufacturing services for the pharmaceutical, healthcare, and bio-technology industries worldwide. More details

540701 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Risk Analysis

Earnings have declined by 54.8% per year over past 5 years

Volatile share price over the past 3 months compared to the Indian market


My Notes

Capture your thoughts, links and company narrative

Dishman Carbogen Amcis Limited Competitors

Vimta Labs

BSE:524394

₹21.0b

Innova Captab

NSEI:INNOVACAP

₹44.9b

Tarsons Products

NSEI:TARSONS

₹16.2b

Windlas Biotech

NSEI:WINDLAS

₹16.5b

Price History & Performance

Summary of share price highs, lows and changes for Dishman Carbogen Amcis
Historical stock prices
Current Share Price₹220.35
52 Week High₹307.80
52 Week Low₹132.75
Beta1.33
1 Month Change-6.67%
3 Month Change-3.59%
1 Year Change-10.28%
3 Year Change32.26%
5 Year Change185.61%
Change since IPO-37.27%

Recent News & Updates

Recent updates

Shareholder Returns

540701IN Life SciencesIN Market
7D8.3%-1.4%0.3%
1Y-10.3%40.0%-1.4%

Return vs Industry: 540701 underperformed the Indian Life Sciences industry which returned 40% over the past year.

Return vs Market: 540701 underperformed the Indian Market which returned -1.4% over the past year.

Price Volatility

Is 540701's price volatile compared to industry and market?
540701 volatility
540701 Average Weekly Movement8.2%
Life Sciences Industry Average Movement6.7%
Market Average Movement6.6%
10% most volatile stocks in IN Market9.3%
10% least volatile stocks in IN Market4.4%

Stable Share Price: 540701's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: 540701's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
19831,132Arpit Vyasimdcal.com

Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical, healthcare, and bio-technology industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients (APIs), and general and highly potent APIs; specialty chemicals comprising intermediates, fine chemicals, phosphoranes, solid quaternary ammonium compounds, wittig reagents, and various pharmaceutical and cosmetic-related products; vitamin D products and its analogues; hand and body wash, sanitizers, and antiseptics; and phase transfer catalysts, soft gel capsules, disinfectant formulations, cholesterol, lanolin-related products, and liquid and lyophilized sterile injectables.

Dishman Carbogen Amcis Limited Fundamentals Summary

How do Dishman Carbogen Amcis's earnings and revenue compare to its market cap?
540701 fundamental statistics
Market cap₹34.63b
Earnings (TTM)-₹1.10b
Revenue (TTM)₹26.50b

1.3x

P/S Ratio

-31.5x

P/E Ratio

Is 540701 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
540701 income statement (TTM)
Revenue₹26.50b
Cost of Revenue₹7.05b
Gross Profit₹19.45b
Other Expenses₹20.55b
Earnings-₹1.10b

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-7.00
Gross Margin73.40%
Net Profit Margin-4.14%
Debt/Equity Ratio43.7%

How did 540701 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/22 20:48
End of Day Share Price 2025/02/21 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Dishman Carbogen Amcis Limited is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shikha JainAnand Rathi Shares and Stock Brokers Limited
Nikhil ShettyBP Wealth Management Private Limited
Nitin AgarwalDAM Capital Advisors